Learn

In this clinical audit, you will conduct an assessment of patients who are at risk of metabolic associated fatty liver disease (MAFLD), calculate their risk of liver fibrosis using validated tools and decide on further management

Details

At the end of this program you will be able to:

• Assess patients who are at risk of metabolic associated fatty liver disease (MAFLD) and identify their risk factors.
• Calculate patients’ risk level of liver fibrosis using validated tools.
• Develop guidelines-based plans for patients’ ongoing management in primary care.
• Identify patients who should be referred to specialist care, and collect appropriate information for a quality referral.

Disclaimer: Please note, once you click 'Register now' you will be leaving the AMA’s CPD Home website and entering a third-party education provider’s website. If you choose to register for this learning, you will need to provide some of your personal information directly to the third-party education provider. If you have any queries about how third-party education providers use, disclose or store your personal information you should consult their privacy policy.